Tag: big pharma and lobbying

In this interview, Jon Jureidini talks about the issues with evidence-based medicine and describes what led to the debasement of a system originally conceived to challenge extravagant claims and poor science.

From Bloomberg: The Pharmaceutical Research and Manufacturers of America (PhRMA) spent $9.96 million on federal lobbying in the first three months of 2018, representing an...

From MedCityNews: This year, under the threat of legislation that may reduce drug prices, address the opioid crisis, and repeal and replace the Affordable Care...

Reporting for The Intercept, Lee Fang reveals that pharma executives "have told investors that they are working actively to influence the political debate.” After...